GlobeNewswire by notified

World heading for a 3-degree C warming trajectory, as political headwinds slow the energy transition

Share


To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

World heading for a 3-degree C warming trajectory, as political headwinds slow the energy transition

WoodMac report looks at the implications of a delayed energy transition, amid political uncertainties, inflation and elections across the world

LONDON, 02 May 2024 – A five-year delay to the energy transition could see the global average temperature rise to 3-degree Celsius above pre-industrial levels, according to Wood Mackenzie’s latest analysis: ‘A delayed energy transition’.

Wood Mackenzie’s delayed energy transition scenario, which analysed the impact a five-year delay might have on global decarbonisation efforts, expects annual average spending to fall to US$1.7 trillion. This is 55% lower than Wood Mackenzie’s net zero 2050 scenario*, which maps out what’s required to meet the Paris Agreement targets.

In terms of total investment, a delayed transition could cost up to US$48 trillion, a significant decrease from Wood Mackenzie’s net zero scenario, which estimates a total of US$75 trillion. The oil and gas sector CAPEX rises to 31%, as power sector spending is expected to remain at its current level of 60%, in a delayed transition. Spending could fall to under 10% in the net zero scenario if the power sector gets 80% of total spend.

For metals and mining sectors, CAPEX is the most resilient and remains around 6% of the total cross all scenarios. In contrast, despite their key role in the overall energy transition, investment into hydrogen and carbon, capture, utilisation, and storage (CCUS) drop to 2%, compared to 8% in Wood Mackenzie’s net zero scenario.

“With half of the global population heading to polls in 2024, political realities and climate scepticism in the major emitting countries, such as the US and Europe, could reduce the support for the transition as voters seek economic security and price stability,” said Prakash Sharma, Vice President, Scenarios and Technologies at Wood Mackenzie, and author of the report.

“The global stocktake at COP28 in December 2023 also confirmed that no major country was on track to meet the Paris aligned commitments and that strong policy action and capital investment were necessary to accelerate the transition. Indeed, Europe and the UK have already pushed back 2030 climate goals and other countries may follow suit,” Sharma added.

According to the scenario, emissions are expected to peak in 2032 and the remaining carbon budget for a 1.5 ˚C world will be used up by 2027, further weakening countries’ ability to deliver the Paris Agreement goals in time by 2050.

Renewables-led electrification looks increasingly more challenging, in Wood Mackenzie’s delayed scenario. Solar and wind dominate power markets in the longer term, but near-term additions are slowed due to transmission bottlenecks. Unabated thermal supply provides much of the flexible generation to balance power grids.

Higher interest rates and supply chain bottlenecks raised renewables costs by 10% to 20% in recent years. Expensive renewables costs will further delay low-carbon hydrogen cost declines, reducing demand to 100 million tonnes (Mt) in 2050, nearly 50% lower than the base case.

A slower transition means carbon capture and removal technologies would need to play a dominant role in restoring the carbon balance and achieving long-term climate goals. CCUS uptake reaches 225 Mt by 2030 in Wood Mackenzie’s delayed transition and continues to scale as policy incentives expand and storage infrastructure is built.

In the delayed transition scenario, oil demand peaks at 114 million barrels per day (mb/d) in 2033, nearly 6 mb/d higher than the base case due to slower electric vehicle (EV) adoption outside China. Gas demand peaks at 4,536 billion cubic meters of natural gas (bcm) in 2045, nearly 100 bcm higher than the base case. Meanwhile coal demand falls slowly, keeping a 3% higher trajectory than the base case in this decade.

“Lower renewables and hydrogen production create headroom for additional gas demand growth, but coal’s resilience limits upside. Commodity markets look tighter and volatile for longer unless investment in supply picks up,” Sharma said.

ENDS

Editor’s Notes:

This report is part of Wood Mackenzie’s Energy Transition Outlook series.

Wood Mackenzie published its most recent base case outlook in September 2023. Since then, the risks of delays in the transition to low-carbon energy have grown, particularly because of shifts in policy and politics in several key economies. As a result, we are publishing here a Delayed Energy Transition scenario, looking at the implications of a five-year delay to global decarbonisation efforts.

Scenario definitions*:

  • Base case - Wood Mackenzie’s base case view across all commodity and technology business units – our central, most likely outcome.
  • Country pledges scenario - Wood Mackenzie’s scenario on how country pledges may be implemented in the future. The 2˚C trajectory aligns with the upper temp limit from the Paris Agreement.
  • Net zero 2050 scenario - Wood Mackenzie’s scenario on how a 1.5˚C world may play out over the next 30 years. Carbon emissions align with the most ambitious goal of the 2015 ​Paris Agreement.
  • Delayed energy transition scenario - the implications of a five-year delay to global decarbonisation efforts modelled in the base case.

Relevant news and commentary

For further information please contact:

Vivien Lebbon, T: +44 330 174 7486, E: Vivien.lebbon@woodmac.com

About Wood Mackenzie
Wood Mackenzie is the global insight business for renewables, energy and natural resources. Driven by data. Powered by people. In the middle of an energy revolution, businesses and governments need reliable and actionable insight to lead the transition to a sustainable future. That’s why we cover the entire supply chain with unparalleled breadth and depth, backed by over 50 years’ experience in natural resources. Today, our team of over 2,000 experts operate across 30 global locations, inspiring customers’ decisions through real-time analytics, consultancy, events and thought leadership. Together, we deliver the insight they need to separate risk from opportunity and make bold decisions when it matters most. For more information, visit woodmac.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Constellation Brands to Present at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 202416.5.2024 22:30:20 CEST | Press release

VICTOR, N.Y., May 16, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that Bill Newlands, President and Chief Executive Officer, and Garth Hankinson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 2024 in New York, NY. The presentation is scheduled to begin at 2:30 p.m. EDT and is expected to cover the company’s strategic business initiatives, financial metrics, and operating performance, as well as outlook for the future. A live, listen-only webcast of the presentation will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the presentation begins, financial information discussed in the presentation, and a reconciliation of reported GAAP financial measures with comparable and other non-GAAP financial measures, will also be available

DBV Technologies Announces Results of its 2024 Combined General Meeting16.5.2024 22:30:00 CEST | Press release

Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting (the “General Meeting”). The General Meeting was chaired by Michel de Rosen, Chairman of the Company. The Company’s shareholders approved all resolutions submitted by the Board of Directors. These resolutions and their results are posted on the Investors/Annual General Meetings section of the Company’s website: https://dbv-technologies.com/events/2024-annual-general-meeting/. About DBV Technologies DBV Technologies is a clinical-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with sign

Clean Motion AB delårsredogörelse för januari-mars 202416.5.2024 22:10:00 CEST | Pressemelding

Elfordonstillverkaren Clean Motion AB presenterar sin delårsrapport för januari-mars 2024. Bolaget redovisar en försäljning på 38 (45) TSEK och ett rörelseresultat exklusive avskrivningar (EBITDA) på -2 949 (-1 825) TSEK. Bolaget meddelar även att ett licensavtal är tecknat för tillverkning av Zbee i Indien samt att deras nya produktionslokal för EVIG i Jonsered nu är godkänd. Sofia Haby, VD kommenterar; ”Vi har jobbat intensivt under kvartalet med både typgodkännande-processen och flytt till nya lokaler. Kvartalet har präglats av de förseningar som vi drabbats av med vårt typgodkännande, vilket förhindrat försäljning i Europa. Jag kan nu med glädje meddela att det mest kritiska testet blev godkänt igår kväll! Under de senaste månaderna har vi jobbat med att färdigställa vår nya produktionslokal i Jonsered. Jag är övertygad om att vi genom att samla alla resurser under ett tak, kommer att åstadkomma stora effektivitetsförbättringar. Teamet har arbetat dedikerat med att säkerställa en s

Galapagos creates new subscription right plans16.5.2024 22:01:00 CEST | Press release

Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries. On 16 May 2024, the Board of Directors of Galapagos approved “Subscription Right Plan 2024 BE”, intended for members of personnel of the company, “Subscription Right Plan 2024 RMV,” intended for the employees of its French subsidiary, Galapagos SASU, and “Subscription Right Plan 2024 ROW”, primarily intended for the employees of its other non-Belgian subsidiaries, within the framework of the authorized capital. Under these subscription right plans, 1,614,000 subscription rights were created, subject to acceptances, and offered to the beneficiaries of the plans. The subscription rights have an exercise term of eight years as of the date of the offer and have an exercise price of €

Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH16.5.2024 22:00:00 CEST | Press release

The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.The recommendation was based on the unblinded review by the DMC of safety data from more than 900 patients randomized in the main and exploratory cohorts, including more than 360 and 80 patients that have been treated for more than 48 and 72 weeks, respectively.The patient who experienced the adverse event of increased liver test results, which was reported as a SUSAR, has been without clinical symptoms throughout the period of observation and has fully recovered.The DMC review confirms the good safety profile of lanifibranor. Daix (France), Long Island City (New York, United States), May 16, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepa

HiddenA line styled icon from Orion Icon Library.Eye